Physician Education Tool: Building confidence delivering lorlatinib treatmentfor ALK+ mNSCLC and managing adverse events
Empower your clinical practice with expert-led strategies for managing lorlatinib-associated neurocognitive adverse events in community oncology, ensuring confident care for your ALK+ NSCLC patients.
Download this Physician Education Tool to build your confidence in initiating lorlatinib treatment and identifying and managing adverse events associated with the treatment.
Supported by unrestricted educational funding from Pfizer.
